Neurology Case Kyle Carpenter PGY III.

Slides:



Advertisements
Similar presentations
Clinical Phenomenology and Neuroimaging Correlates in ALS-FTD
Advertisements

MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
 Most common and important degenerative disease of the brain  Shrinkage in size and weight of the brain  Severe degree of diffuse cerebral atrophy.
Motor neuron disease What are motor neuron diseases? Who is at risk? What are the causes motor neuron diseases? How are they classified? What are the symptoms.
Frontotemporal Dementia
Approach to Nervous System Dr. Amal Alkhotani MD, FRCPC Neurology,EEG & Epilepsy
4 patients falling over. Mrs April Aged 62 Complains of tripping up when she walks on uneven surfaces Falls over and comes to hospital PMH COPD Vegan.
Dementia with Lewy Bodies
Part I Mr. Robert Middelton … Over the past few years, he noticed...a slowly developing weakness initially in his hands and arms, now spreading to his.
Chapter 2 Syndromes, Developmental Disabilities, and Motor and Sensory Impairments that Affect Language and Speech.
University of Kansas Medical Center
ACT on Alzheimer’s Disease Curriculum Module VII: Disease Diagnosis.
DEMENTIA By: Angela Pabon. What is Dementia? Dementia does not always mean that one has Alzheimer's disease, there are over 80 forms of dementia The definition.
A 67-year-old male with behavioral and language problems
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Chapter 15 - Cognitive Disorders I.Delirium Acute, temporary impairment in perception & cognition Fluctuating course.
Language and dementia What is dementia? A progressive decline of mental abilities, accompanied by changes in personality and behaviour. There is commonly.
Huntington’s Disease By: Ari Naccarato (Press space bar to change slides and make sure the volume is up!)
Amyotrophic Lateral Sclerosis
Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,
DEMENTIA AND ALZHEIMER'S DISEASE. IMPAIRMENT OF BRAIN FUNCTION ( DECLINE IN INTELLECTUAL FUNCTIONING) THAT INTERFERES WITH ROUTINE DAILY ACTIVITIES. MENTAL.
LOU GEHRIG’S DISEASE.  Also known as Amyotrophic Lateral Sclerosis  Is a disease of the nerve cells in the brain and spinal cord that control voluntary.
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
BY DR ZAINAB ABDULZAEEZ UMAR DEPARTMENT OF FAMILY MEDICINE AMINU KANO TEACHING HOSPITAL.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Amyotrophic Lateral Sclerosis (ALS)
 Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer’s is the most common form of dementia. This.
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
Amyotrophic Lateral Sclerosis. Motor Neuron Disease Terminology Lower motor neuron Upper motor neuron Progressive Muscular Atrophy Amyotrophic Lateral.
ALS by Cheetahs.  Güldeniz Karakuş  Abide Yıldız  Zeynep Özal  Esra Akman.
漸凍症 amyotrophic lateral sclerosis. Lou Gehrig's disease 1939 Jean-Martin Charcot Amyotrophic lateral sclerosis (ALS) (Rosen DR et al. Nature 1993) 1869.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
NYU Medical Grand Rounds Clinical Vignette Megha Shah PGY-2 November 10, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Focal Syndromes Dr Stephen Pearson Consultant in Old Age Psychiatry Devon Partnership Trust.
Neurological Disorders
Amyotrophic Lateral Sclerosis (ALS)
ALS Samuel Awad & Osama Jamali. Introduction ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds.
Teaching NeuroImages A 54-year-old man with progressive muscle weakness, hand tremor, tongue and perioral fasciculation Neurology Resident and Fellow Section.
Amyotrophic lateral sclerosis
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Charcot-Marie- Tooth Disease Jessica Tzeng. History  Named after Jean-Martin Charcot, Pierre Marie (Charcot’s pupil), and Howard Henry Tooth  Not a.
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
Motor neuron disease.
Mariano Musacchio 1 François Sellal 2 Frédéric Blanc 2 Jean-Marc Michel 2 Stephan Kremer 3 Jean-Louis Dietemann 3 1 Department of Neuroradiology - CHG.
Alzheimer's By Emily Toro Period 1.
Amyotrophic Lateral Sclerosis (ALS). Also know as Lou Gehrig's Disease Named after the New York Yankees baseball star who played first base and was diagnosed.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
Memory and Aging Educational Presentation Presented by Tessa Lundquist, M.S. University of Massachusetts Amherst.
Frontotemporal Lobar Degeneration:
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Amyotrophic Lateral Sclerosis (ALS)
The Malfunctioning Mind: Degenerative Diseases of the Brain
Dementia Jaqueline Raetz, M.D..
AMYOTROPHIC LATERAL SCLEROSIS
By: Johanna Miner, Kendra Hobbs and Ainsley MAcDonald
Unit 40 Dementia care.
Dementia Jaqueline Raetz, M.D..
Amyotrophic Lateral Sclerosis
What does this protein make up or do? amyotrophic lateral sclerosis
Long Term Effects of Concussions
What is Dementia? A term that describes a wide range of symptoms associated with a decline in memory or other thinking skills. Dementia may be severe.
Atypical Parkinsonian Syndromes
First they said she had schizophrenia and now she cant remember
Nat. Rev. Neurol. doi: /nrneurol
IBMPFD/ALS, MSP or VCP disease
Patient 2- Alzheimer’s Disease
The Memory Assessment and Treatment Service (MATS)
Presentation transcript:

Neurology Case Kyle Carpenter PGY III

History of Present Illness 60 year old left handed male Chief complaint- difficult speaking, frequent falls On his first visit his wife noted that for past 2 years the patient’s language and vocabulary had suffered He was having trouble recalling words that he wanted to say e.g. he was formerly a mechanic and was having trouble remembering names of tools His short term memory had also progressively worsened during this same time Also for about one year prior had been falling frequently (1- 2 times per week) Difficulty swallowing and crying spells for no apparent He was no longer paying bills or driving

Past medical history Social Hypertension Diabetes (A1C of 8.9%) Hyperlipidemia GERD Depression Social Stopped smoking and drinking 20 years prior Surgery CTS in 2011 Kidney stone

Exam Mental status Speech Cranial Nerves Can name correct city, and year but not month or day Naming intact. 2/3 object at 5min recall Comprehension intact but perseverates Speech Fluent but with severe word finding difficulty Only 8 objects on “D” test (12 is normal) Decreased emotion in speech Cranial Nerves Intact Orbicularis oculi 5/5 Tongue strength is normal

Exam NF NE Motor Reflexes Gait Cerebellar Sensory Tone is normal Atrophy of FDI Exam Reflexes 3+ in bilaterally UE 3+ Patella 0 Ankle Downgoing toes Gait Wide based, slow, unable to walk heel to toe Cerebellar FNF intact but slo Sensory Difficult to assess but likely intact to all modalities Right Left NF 5 NE SA 4 EF EE WF WE HF 4+ HE KF KE DF PF

Second Visit CT head showed moderate cortical atrophy Seen in clinic three months later Almost completely anomic. 1-2 words at the most Unable to answer orientation questions Could follow 1 step commands but nothing more complicated Confined to a wheelchair, diffuse weakness Further atrophy of hands, arms, legs Fasciculations seen in leg and arm muscles Further testing was done

Where? What?

Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

FTD-ALS Each disease is typically diagnosed separately 15% of ALS patients have FTD 10% of FTD patients Slightly more common in men than women Cognitive symptoms typically occur first but motor symptoms can occur before or simultaneously Interval is 3 months to 7 years with mean of 2 years Survival is worse in FTD-ALS patients than ALS without dementia A proposed classification scheme ALSci (cognitively impaired) ALSbi (behaviorally impaired) ALS-FTD (meet Neary Criteria) FTD-MND (patients who have motor neuron loss at autopsy but no clinical signs) ALS-dementia (Alzheimer's or vascular) M. J. Strong, G. M. Grace, M. Freedman, et al., “Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis,”Amyotrophic Lateral Sclerosis, vol. 10, no. 4, pp. 131–146, 2009.

Amyotrophic Lateral Sclerosis ALS used interchangeably with ‘Motor Neuron Disease’ and ‘Lou Gehrig's Disease’ Diagnosed clinically with a mixture of upper motor neuron signs and lower motor neuron signs Progressive weakness that can begin in legs, arms or bulbar region Atrophy and fasciculation (LMN) Hyperreflexia, upgoing toes, jaw jerk (UMN) EMG shows active denervation and reinnervation First described in 1869 by Charcot Marie in 1892 reported on behavioral changes in ALS patients Entrenched in Neurology that body wasted and mind was spared In late 80s Stan Appel and Forbes Norris developed clinics devoted to ALS clinics This concept spread to major centers allowing Neurologists to develop large ALS patient populations Reports were generated linking ALS and dementia Criteria for FTD were published in 1998 and ALS and FTD were linked

FRONTOTEMPORAL DEMENTIA Symptoms Insidious onset with slow progression Age 50-60 Types Behavioral variant (bvFTD) Disinhibition, apathy, behavior changes (next slide) Primary Progressive Aphasia Decreased expression of language, anomia Relative preservation of comprehension Semantic Dementia (now considered a variant of PPA) Fluent grammatically correct speech but empty of content Loss of executive function early is seen in all three Typically preservation of short term memory, praxis and visualospatial skills Diagnosed via Neary Criteria (other criteria have been suggested)

Table 1: Behavioral features in FTLD Disinhibited type  Increased interest in sexual activity  Lack of judgment  Swearing  Violation of personal space  Impulsive buying  Paranoia  Criminal activity  Grandiose thinking  Ignoring social etiquette Apathetic type  Blunted emotions  Disinterested and withdrawn  Lack of attention to personal hygiene  Lack of empathy Stereotypical type  Hoarding  Food fads, overeating  Ritualistic/repetitive behavior

Testing FTD in ALS patients Can be difficult to test for language disorders due to bulbar weakness (dysarthria), hand weakness impairs writing Cognitive changes can be seen in patients follows in specialty clinics Comprehension in pulmonary testing Spelling and grammatical errors Various studies and questionnaires have used to identify dementia in ALS patients CANTAB Computer touch screen and Neurologist opinion Memory loss 7%, FTD criteria 22% Caregiver questionnaire NPI, FBI, CBI, FrSBe Apathy 56%, stereotypical behaviors 20%, executive dysfunction 34-48%, disinhibition 18-27% 11% meet criteria for FTD CANTAB- Cambridge Neuropsychological Test Automated Battery NPI- Neuropsychiatric Inventory FBI- Frontal Behavioral Inventory CBI- Cambridge Behavioral Inventory FrSBe- Frontal Systems Behavioral Scale MMSE- Mini mental Status Exam

FTD In ALS 2003 study of 100 patients screened with verbal fluency and MMSE 31 had abnormal fluency (“D” or animal test). 50% of bulbar onset patients had abnormal exam, 25% of limb onset patients All had normal MMSE 2012 study of 160 patients with formal neuropsych testing 14% met FTD-Neary criteria, 21% had cognitive impairment and 47% were normal 2005 study of 279 patients 15% with FTD, 49% normal cognition, 43% cognitive impairment ALS patients over time- 52 patients every 4 months showed abnormal at onset did not show decline

FTD in ALS 2009 AAN practice parameter acknowledged lack of consensus of screening tool ALS Cognitive Behavioral Screen- has been validated 15 caregiver questions 8 item physician assessment 5 min Penn State Screen Battery of Frontal and Temporal Dysfunction Syndrome 20 minutes Not validated UCSF Screen Battery 45 minutes, includes ALS specific FBI and depression screen

ALS in FTD patients Studies have had varied results 2002 study of 36 FTD patients with detailed neuromuscular exam and EMG 5 had definite ALS, 5 had fasciculations on EMG and 1 of these developed definite ALS 1 year later 2008 retrospective study of FTDbv 18 of 61 developed definite ALS

Genetics Various genetic mutations have been linked to both familial ALS and FTD Familial cases are far outnumbered by sporadic cases in both disorders (10% of ALS and 40% of FTD) Three most important genes associated with FTD are microtubule associated protein tau (MAPT), progranulin and C9ORF72 Mutations in the SOD1 gene are most common in familial ALS Two studies in 2012 found a mutation in the C9ORF72 gene that occurred in both ALS and FTD. This was the first genetic link between the two diseases Progranulin and C9ORF72 mutations can deposition of TAR-DNA binding protein 43 (TDP-43) TDP-43 is an ubiquinated protein that has been found to accumulate in both ALS and FTD

Sources ALS and Frontotemporal Dysfunction: A Review. Eugene Y. Achi and Stacy A. Rudnicki Neurology Research International Volume 2012 (2012), Article ID 806306, 9 pages doi:10.1155/2012/806306 Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257–268 Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134(pt 9):2456Y2477 M. J. Strong, G. M. Grace, M. Freedman, et al., “Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis,”Amyotrophic Lateral Sclerosis, vol. 10, no. 4, pp. 131–146, 2009.